AHR · Insider Trading
American Healthcare REIT, Inc.
Every open-market purchase and sale reported by AHR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-28 | Mark E. Foster | EVP, GC & Secretary | Sell | −1,500 | −$78.09K |
| 2026-09-01 | Mark E. Foster | EVP, GC & Secretary | Sell | −2,000 | −$110.78K |
| 2026-08-04 | Danny Prosky | Director | A | +2,594 | — |
| 2026-07-22 | Jeffrey T Hanson | Chief Executive Officer | A | +35,981 deriv. | — |
| 2026-07-22 | Gabriel M Willhite | President & COO | A | +6,038 deriv. | — |
| 2026-07-22 | Danny Prosky | Director | MIXED | −33,499 | −$4.98M |
| 2026-06-29 | Brian Peay | Chief Financial Officer | Sell | −25,000 | −$1.27M |
| 2026-06-26 | Brian J. Flornes | Director | A | +2,594 | — |
| 2026-06-26 | Marvin R O'Quinn | Director | A | +2,594 | — |
| 2026-06-26 | Mark E. Foster | EVP, GC & Secretary | Sell | −2,500 | −$121.45K |
| 2026-06-26 | Scott A Estes | Director | A | +2,594 | — |
| 2026-06-26 | Dianne Hurley | Director | A | +2,594 | — |
| 2026-06-26 | Mathieu B. Streiff | Director | A | +2,594 | — |
| 2026-06-26 | Valerie Richardson | Director | A | +2,594 | — |
| 2026-06-26 | Wilbur H Smith III | Director | A | +2,594 | — |
| 2026-06-03 | Mark E. Foster | EVP, GC & Secretary | Sell | −2,000 | −$96.64K |
| 2026-04-08 | Danny Prosky | Director | MIXED | +7,328 | −$413.38K |
| 2026-04-08 | Brian Peay | Chief Financial Officer | MIXED | +3,114 | −$175.72K |
| 2026-04-08 | Gabriel M Willhite | Chief Operating Officer | MIXED | +3,114 | −$175.72K |
| 2026-04-08 | Stefan K.L. Oh | Chief Investment Officer | MIXED | +1,564 | −$77.95K |
| 2026-04-08 | Mark E. Foster | EVP, GC & Secretary | MIXED | +1,374 | −$77.52K |
| 2026-03-30 | Jeffrey T Hanson | Interim CEO and President | A | +42,756 deriv. | — |
| 2026-03-27 | Danny Prosky | Director | MIXED | +25,441 | −$1.27M |
| 2026-03-27 | Brian Peay | Chief Financial Officer | MIXED | +10,767 | −$538.23K |
| 2026-03-27 | Gabriel M Willhite | Chief Operating Officer | MIXED | +7,467 | −$373.36K |
| 2026-03-27 | Stefan K.L. Oh | Chief Investment Officer | MIXED | +6,992 | −$349.57K |
| 2026-03-27 | Mark E. Foster | EVP, GC & Secretary | MIXED | +3,456 | −$369.81K |
| 2026-03-16 | Danny Prosky | Director | MIXED | +14,665 | −$907.16K |
| 2026-03-16 | Brian Peay | Chief Financial Officer | MIXED | +6,232 | −$385.55K |
| 2026-03-16 | Gabriel M Willhite | Chief Operating Officer | MIXED | +6,232 | −$385.55K |
| 2026-03-16 | Stefan K.L. Oh | Chief Investment Officer | MIXED | +2,933 | −$181.47K |
| 2026-03-16 | Mark E. Foster | EVP, GC & Secretary | MIXED | +2,750 | −$170.12K |
| 2026-02-11 | Danny Prosky | CEO & President | F | −29,992 | −$1.46M |
| 2026-02-11 | Brian Peay | Chief Financial Officer | F | −20,109 | −$980.72K |
| 2026-02-11 | Gabriel M Willhite | Chief Operating Officer | F | −17,133 | −$835.58K |
| 2026-02-11 | Stefan K.L. Oh | Chief Investment Officer | F | −10,166 | −$495.80K |
| 2026-02-11 | Mark E. Foster | EVP, GC & Secretary | F | −7,685 | −$374.80K |
| 2025-12-29 | Jeffrey T Hanson | Director | Sell | −54,778 | −$2.65M |
| 2025-11-12 | Mark E. Foster | EVP, GC & Secretary | Sell | −1,500 | −$74.03K |
| 2025-11-10 | Jeffrey T Hanson | Director | Sell | −20,010 | −$994.10K |
| 2025-09-05 | Mark E. Foster | EVP, GC & Secretary | Sell | −3,850 | −$161.27K |
| 2025-07-02 | Stefan K.L. Oh | Chief Investment Officer | Sell | −3,860 | −$139.35K |
| 2025-06-27 | Jeffrey T Hanson | Director | A | +3,042 | — |
| 2025-06-27 | Scott A Estes | Director | A | +3,042 | — |
| 2025-06-27 | Brian J. Flornes | Director | A | +3,042 | — |
| 2025-06-27 | Dianne Hurley | Director | A | +3,042 | — |
| 2025-06-27 | Valerie Richardson | Director | A | +3,042 | — |
| 2025-06-27 | Wilbur H Smith III | Director | A | +3,042 | — |
| 2025-06-27 | Mathieu B. Streiff | Director | A | +3,042 | — |
| 2025-06-27 | Marvin R O'Quinn | Director | A | +3,042 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Danny Prosky | Director | 514,995 | $27.22M |
| Mathieu B. Streiff | Director | 192,373 | $10.17M |
| Brian Peay | Chief Financial Officer | 153,507 | $8.11M |
| Gabriel M Willhite | President & COO | 151,819 | $8.03M |
| Stefan K.L. Oh | Chief Investment Officer | 96,994 | $5.13M |
| Mark E. Foster | EVP, GC & Secretary | 50,117 | $2.65M |
| Wilbur H Smith III | Director | 35,013 | $1.85M |
| Dianne Hurley | Director | 34,037 | $1.80M |
| Brian J. Flornes | Director | 33,020 | $1.75M |
| Jeffrey T Hanson | Chief Executive Officer | 22,527 | $1.19M |
| Scott A Estes | Director | 21,489 | $1.14M |
| Marvin R O'Quinn | Director | 20,656 | $1.09M |
| Valerie Richardson | Director | 20,656 | $1.09M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AHR quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.